Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | 0.00% | -2.86% | +9.68% |
01:41pm | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
Apr. 16 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
Financials (USD)
Sales 2024 * | 189M | Sales 2025 * | 171M | Capitalization | 285M |
---|---|---|---|---|---|
Net income 2024 * | -63M | Net income 2025 * | -63M | EV / Sales 2024 * | 1.51 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
-4.69
x | P/E ratio 2025 * |
-4.74
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.79% |
Latest transcript on Akebia Therapeutics, Inc.
1 week | -2.16% | ||
Current month | -25.68% | ||
1 month | -37.33% | ||
3 months | -2.16% | ||
6 months | +63.88% | ||
Current year | +9.68% |
Managers | Title | Age | Since |
---|---|---|---|
John Butler
CEO | Chief Executive Officer | 59 | 13-06-30 |
Tracey Vetterick
ADM | Chief Administrative Officer | - | 22-03-31 |
Michel Dahan
COO | Chief Operating Officer | 45 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Rogers
BRD | Director/Board Member | 64 | 18-12-11 |
Adrian Adams
CHM | Chairman | 73 | 18-12-11 |
Director/Board Member | 65 | 21-02-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.36 | 0.00% | 2 030 640 |
24-04-22 | 1.36 | 0.00% | 2,006,106 |
24-04-19 | 1.36 | -2.16% | 2,956,394 |
24-04-18 | 1.39 | 0.00% | 2,562,577 |
24-04-17 | 1.39 | -0.71% | 2,944,347 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.68% | 285M | |
-1.71% | 103B | |
+2.49% | 96.73B | |
-0.03% | 21.31B | |
-16.61% | 21.21B | |
-6.45% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B |
- Stock Market
- Equities
- AKBA Stock